# A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers

> **NCT07143331** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Klotho Sciences Australia Pty Ltd.** · enrollment: 84 (estimated)

## Conditions studied

- Healthy Participants
- Alzheimer Disease
- Chronic Kidney Disease

## Interventions

- **DRUG:** Part 1 KS101
- **DRUG:** Part 1 Placebo
- **DRUG:** Part 2 with Food
- **DRUG:** Part 2 without food
- **DRUG:** Part 3 KS101

## Key facts

- **NCT ID:** NCT07143331
- **Lead sponsor:** Klotho Sciences Australia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-30
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-08-06
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07143331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07143331, "A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07143331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*